ArticleCancer science2022

LRFN2 binding to NMDAR inhibits the progress of ESCC via regulating the Wnt/β-Catenin and NF-κB signaling pathway.

Yu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.